Cargando…
Autoimmune Hemolysis: A Journey through Time
The existence of autoimmune diseases in humans has been known for almost 100 years. Currently, autoimmune pathogenesis has been attributed to more than 40 human diseases; yet it is still not clear what immune abnormalities conclusively prove underlying autoimmune pathogenesis. Hence, although much h...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678316/ https://www.ncbi.nlm.nih.gov/pubmed/26696795 http://dx.doi.org/10.1159/000437195 |
_version_ | 1782405434482622464 |
---|---|
author | Freedman, John |
author_facet | Freedman, John |
author_sort | Freedman, John |
collection | PubMed |
description | The existence of autoimmune diseases in humans has been known for almost 100 years. Currently, autoimmune pathogenesis has been attributed to more than 40 human diseases; yet it is still not clear what immune abnormalities conclusively prove underlying autoimmune pathogenesis. Hence, although much has been learned, research is still needed for complete elucidation of the mechanisms of the immune dysregulation in AIHA. Better understanding of the underlying mechanism(s) may allow for development of more specific therapies of these not uncommon and often difficult-to-treat disorders. |
format | Online Article Text |
id | pubmed-4678316 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-46783162015-12-22 Autoimmune Hemolysis: A Journey through Time Freedman, John Transfus Med Hemother Review Article The existence of autoimmune diseases in humans has been known for almost 100 years. Currently, autoimmune pathogenesis has been attributed to more than 40 human diseases; yet it is still not clear what immune abnormalities conclusively prove underlying autoimmune pathogenesis. Hence, although much has been learned, research is still needed for complete elucidation of the mechanisms of the immune dysregulation in AIHA. Better understanding of the underlying mechanism(s) may allow for development of more specific therapies of these not uncommon and often difficult-to-treat disorders. S. Karger AG 2015-09 2015-08-10 /pmc/articles/PMC4678316/ /pubmed/26696795 http://dx.doi.org/10.1159/000437195 Text en Copyright © 2015 by S. Karger GmbH, Freiburg http://www.karger.com/Authors_Choice This is an open access article distributed under the terms of Karger's Author's Choice™ licensing agreement, adapted from the Creative Commons Attribution Non-Commercial 2.5 license. This license allows authors to re-use their articles for educational and research purposes as long as the author and the journal are fully acknowledged. |
spellingShingle | Review Article Freedman, John Autoimmune Hemolysis: A Journey through Time |
title | Autoimmune Hemolysis: A Journey through Time |
title_full | Autoimmune Hemolysis: A Journey through Time |
title_fullStr | Autoimmune Hemolysis: A Journey through Time |
title_full_unstemmed | Autoimmune Hemolysis: A Journey through Time |
title_short | Autoimmune Hemolysis: A Journey through Time |
title_sort | autoimmune hemolysis: a journey through time |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678316/ https://www.ncbi.nlm.nih.gov/pubmed/26696795 http://dx.doi.org/10.1159/000437195 |
work_keys_str_mv | AT freedmanjohn autoimmunehemolysisajourneythroughtime |